Literature DB >> 3147093

Coronary flow reserve and the J curve.

.   

Abstract

Mesh：

Substances：

Year:  1988        PMID： 3147093      PMCID： PMC1835270     

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  7 in total

Review 1.  Why has the primary prevention of myocardial infarction in the treatment of hypertension been so elusive?

Authors:  J M Cruickshank
Journal:  J Hum Hypertens       Date:  1987-09       Impact factor: 3.012

2.  Cardiovascular morbidity in relation to change in blood pressure and serum cholesterol levels in treated hypertension. Results from the primary prevention trial in Göteborg, Sweden.

Authors:  O Samuelsson; L Wilhelmsen; O K Andersson; K Pennert; G Berglund
Journal:  JAMA       Date:  1987-10-02       Impact factor: 56.272

3.  Does therapeutic reduction of diastolic blood pressure cause death from coronary heart disease?

Authors:  P C Waller; C G Isles; A F Lever; G D Murray; G T McInnes
Journal:  J Hum Hypertens       Date:  1988-06       Impact factor: 3.012

4.  Benefits and potential harm of lowering high blood pressure.

Authors:  J M Cruickshank; J M Thorp; F J Zacharias
Journal:  Lancet       Date:  1987-03-14       Impact factor: 79.321

5.  Low mortality from all causes, including myocardial infarction, in well-controlled hypertensives treated with a beta-blocker plus other antihypertensives.

Authors:  J M Cruickshank; K Pennert; A E Sörman; J M Thorp; F M Zacharias; F J Zacharias
Journal:  J Hypertens       Date:  1987-08       Impact factor: 4.844

6.  The efficacy and tolerability of antihypertensive treatment based on atenolol in the prevention of stroke and the regression of left ventricular hypertrophy.

Authors:  J M Cruickshank; T J Higgins; K Pennert; J M Thorp; F M Zacharias; F J Zacharias
Journal:  J Hum Hypertens       Date:  1987-09       Impact factor: 3.012

7.  Beta-blockers versus diuretics in hypertensive men: main results from the HAPPHY trial.

Authors:  L Wilhelmsen; G Berglund; D Elmfeldt; T Fitzsimons; H Holzgreve; J Hosie; P E Hörnkvist; K Pennert; J Tuomilehto; H Wedel
Journal:  J Hypertens       Date:  1987-10       Impact factor: 4.844
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.